Loading organizations...
Key people at Maruho.
Maruho is a pharmaceutical company that specializes in the research, development, manufacturing, and sale of dermatological products. It provides a comprehensive approach to skin health, consistently managing the process from initial research stages through to product delivery and information dissemination. The company's expertise lies in addressing a wide range of dermatological conditions through its dedicated focus on this medical field.
The company was founded in 1915 by Eikuma Koba, who established Maruho Shoten in the Doshomachi area of Osaka, Japan. Koba’s initial vision was driven by a deep-seated desire to contribute to society through medicine. This founding insight has guided Maruho's operations for over a century, evolving into its present corporate structure, with the current name Maruho Co., Ltd. being adopted in 1965.
Maruho serves individuals seeking advanced treatments and solutions for various skin ailments. Its long-term vision centers on a commitment to enhancing the health and well-being of people worldwide, specifically through advancements in dermatology. The company continues to pursue innovations that fulfill its foundational mission of societal contribution through medical progress.
Key people at Maruho.
Maruho has 2 tracked investments across 2 companies. The latest tracked deal is $200.0M Series A in Upstream Bio in June 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 2, 2022 | Upstream Bio | $200.0M Series A | Maruho, Erez Chimovits, OrbiMed | Access Biotechnology, Altshuler Shaham, Decheng Capital, HBM Healthcare Investments, Omega Funds, Samsara BioCapital, Bernard Davitian, TCGX |
| Jun 1, 2013 | Dermira | $35.0M Series B | — | Canaan Partners, MPM Capital, Pivotal BioVenture Partners, SR ONE, BAY City Capital, Canaan Partners, NEW Enterprise Associates |